Skip to content

Prospective inventory of pre-, peri- and posttherapeutic nutritional status of patients with squamous cell carcinoma in the oral cavity

Prospective inventory of pre-, peri- and posttherapeutic nutritional status of patients with squamous cell carcinoma in the oral cavity

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
DRKS
Registry ID
DRKS00019836
Enrollment
108
Registered
2019-11-11
Start date
2019-11-18
Completion date
Unknown
Last updated
2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Pre-, peri- and posttherapeutic nutritional status of patients with squamous cell carcinoma in the oral cavity

Interventions

Group 1: Patients with squamous cell carcinoma in the oral cavity Screenings are carried out at three different points in time to determine the nutritional status of the patient. 3 screening times:

Sponsors

Mund-, Kiefer- und Gesichtschirurgie Universitätsklinikum Münster
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: Patients of both sexes from an age of 18 years; a histopathologically confirmed plate-epithelial primary tumor in the oral cavity; control group: in-patients with currently treated bimaxillary osteotomy at the age of 18-35 years in good general condition; therapy at the Clinic for maxillofacial surgery in Münster

Exclusion criteria

Exclusion criteria: Minors; pregnant women; patients with pacemakers or ICD (implanted cardioverter defibrillator); patients with a history of tumours (secondary tumours, recurrences); patients with diseases of the gastrointestinal tract that affect dietary intake (e.g. ulcerative colitis, celiac disease, Crohn's disease); refusal to participate in the study

Design outcomes

Primary

MeasureTime frame
Assessment of the pre-, peri- and post-therapeutic nutritional status of patients with squamous cell carcinoma in the oral cavity using three different screening methods (SGA, BMI, bioelectrical impedance analysis)

Secondary

MeasureTime frame
Documentation of complications, hospital stay, well-being and mobility

Countries

Germany

Contacts

Public ContactSebastian Igelbrink

Mund-, Kiefer und Gesichtschirurgie Universitätsklinikum Münster

Sebastian.Igelbrink@ukmuenster.de0251 / 8347002

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 4, 2026